(EMAILWIRE.COM, January 30, 2017 ) According to Publisher, the Global Cancer Vaccines market is accounted for $2.25 billion in 2015 and is expected to reach $10.00 billion by 2022 growing at a CAGR of 23.7%. Factors such as rising number of cancer patients, increasing ageing population and awareness of vaccines are fueling the market. However, less availability of vaccines and advanced treatments in underdeveloped regions may limit the market growth.

North America accounted for the largest share in the market followed by Asia Pacific. The favourable growth is attributed to supportive government and other organisations such as World health organisation and GAVI initiatives.

For more information about this report: http://www.reportsweb.com/cancer-vaccines-global-market-outlook-2016-2022

Some of the key players in Global Cancer Vaccines market include Oxford BioMedica, Vaccinogen Inc., GlaxoSmithKline, Sanofi India Limited-P.P. Enterprises, Juvaris Biotherapeutics, Merk&co, Prima BioMed Ltd, Cytos Biotechnology AG, Ubivac, duro BioTech, AstraZeneca plc., and MedImmune, LLC.

Disease Indication Covered:
- Cervical cancer
- Esophageal cancer
- Liver cancer
- Prostate cancer
- Lung cancer
- Breast cancer
- Stomach cancer

Technologies Covered:
- Inactivated Vaccines
- Peptide/protein vaccines
- Synthetic Vaccines
- Toxoid Vaccines
- Live Attenuated Vaccines
- Recombinant Vector Vaccines
- Antigen vaccines
- Dendritic Cell Vaccines
- Subunit Vaccines
- Heat shock protein vaccines
- DNA- and vector-based vaccines
- Conjugate Vaccines
- Anti-idiotype vaccines
- Cancer stem cell vaccines

End Users Covered:
- Adults
- Paediatrics

Vaccine Types Covered:
- Therapeutic Vaccines
- Preventive Vaccines

Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001564945/sample

Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Company Profiling
11.1 Oxford BioMedica
11.2 Vaccinogen Inc.
11.3 GlaxoSmithKline
11.4 Sanofi India Limited-P.P. Enterprises
11.5 Juvaris Biotherapeutics
11.6 Merk&co
11.7 Prima BioMed Ltd
11.8 Cytos Biotechnology AG
11.9 Ubivac
11.10 duro BioTech
11.11 AstraZeneca plc
11.12 MedImmune, LLC
11.13 Nova Rx Corporation
11.14 Argos Therapeutics
11.15 Prima BioMed Ltd

Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001564945/buying

Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results